The Consortium for the early identification of Alzheimer's disease–Quebec (CIMA-Q)

INTRODUCTION: The Consortium for the early identification of Alzheimer's disease–Quebec (CIMA-Q) created a research infrastructure to recruit, characterize, and track disease progression in individuals at risk of dementia. METHODS: CIMA-Q established standardized clinical, neuropsychological, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Belleville, Sylvie, LeBlanc, Andréa C., Kergoat, Marie-Jeanne, Calon, Frédéric, Gaudreau, Pierrette, Hébert, Sébastien S., Hudon, Carol, Leclerc, Nicole, Mechawar, Naguib, Duchesne, Simon, Gauthier, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Diagnostic Assessment & Prognosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880140/
https://www.ncbi.nlm.nih.gov/pubmed/31788534
http://dx.doi.org/10.1016/j.dadm.2019.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880140/
https://www.ncbi.nlm.nih.gov/pubmed/31788534
http://dx.doi.org/10.1016/j.dadm.2019.07.003

Ejemplares similares